Warby Parker Inc.

WRBY ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $871.9M $771.3M $669.8M $598.1M $540.8M $393.7M $370.5M
Cost of Revenue $401.3M $344.5M $304.5M $257.1M $223.0M $161.8M $147.4M
Gross Profit $470.6M $426.8M $365.2M $341.1M $317.7M $231.9M $223.1M
Gross Margin 54.0% 55.3% 54.5% 57.0% 58.8% 58.9% 60.2%
Operating Expenses
Research & Development
SG&A Expense $475.9M $456.9M $437.2M $452.3M $461.4M $287.6M $224.8M
Operating Income $-5.3M $-30.1M $-72.0M $-111.2M $-143.7M $-55.6M $-1.7M
Operating Margin -0.6% -3.9% -10.7% -18.6% -26.6% -14.1% -0.4%
Interest Expense
Pretax Income $3.0M $-19.5M $-62.8M $-109.9M $-144.0M $-55.7M $276.0K
Income Tax Expense $1.4M $875.0K $433.0K $497.0K $263.0K $190.0K $276.0K
Net Income $1.6M $-20.4M $-63.2M $-110.4M $-144.3M $-55.9M $0
Net Margin 0.2% -2.6% -9.4% -18.5% -26.7% -14.2% 0.0%
EPS (Basic) $0.01 $-0.17 $-0.54 $-0.96 $-2.21 $-1.05 $-1.10
EPS (Diluted) $0.01 $-0.17 $-0.54 $-0.96 $-2.21 $-1.05 $-1.10
Shares Outstanding (Basic) 122.7M 120.4M 117.4M 114.9M 71.2M 53.0M 52.4M
Shares Outstanding (Diluted) 125.1M 120.4M 117.4M 114.9M 71.2M 53.0M 52.4M
Dividends Per Share